Medinova Diagnostic Services Ltd.

View in App
34.29 +1.62 ▲5.0%

23 April 2024, 04:01:00 PM
Volume: 4,157

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.medinovaindia.com
Market Cap 34.23 Cr.
Enterprise Value(EV) 38.36 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 2.18 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 15.75 Trailing Twelve Months Ending 2023-12
Industry PE 66.90 Trailing Twelve Months Ending 2023-12
Book Value / Share -3.72 Trailing Twelve Months Ending 2023-12
Price to Book Value -9.23 Calculated using Price: 34.29
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.00 Cr. 9,981,640 Shares
FaceValue 10
About Medinova Diagnostic Services Ltd.
The Company is engaged in the business of providing comprehensive range of diagnostic services spanning pathological investigations, radiology & imaging, conventional, specialized lab services and diagnostic cardiology.

Medinova Diagnostic Services Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Medinova Diagnostic Services Ltd. Performance

View details >>
1 Day
+4.96%
1 Week
+2.85%
1 Month
+5.28%
3 Month
-27.47%
6 Month
+44.38%
1 Year
+50.46%
2 Year
+0.85%
5 Year
+97.07%
10 Year
+716.43%

Medinova Diagnostic Services Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0 0 0 0 0 0 0 0 0
Return on Capital Employed (%) 0 0 0 0 0 0 0 0 2679.22
Return on Assets (%) -36.06 -18.68 -16.82 -6.27 15.7 -5.45 48.36 60.03 42.82

Medinova Diagnostic Services Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds -7 -9 -10 -10 -9 -9 -7 -7 -5 -4
Non Curr. Liab. 2 7 7 6 4 4 4 5 5 5
Curr. Liab. 15 13 11 10 9 9 8 5 4 4
Minority Int. 0 0 0 0 0 0
Equity & Liab. 10 12 9 6 5 4 4 4 4 5
Non Curr. Assets 7 10 7 5 4 3 2 2 2 2
Curr. Assets 3 2 1 1 1 1 2 2 2 3
Misc. Exp. not W/O
Total Assets 10 12 9 6 5 4 4 4 4 5

Medinova Diagnostic Services Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 8 8 8 9 9 7 13 13 10 10
Other Income 0 0 0 0 0 0 0 0 0
Total Income 8 8 8 9 9 8 13 13 10 11
Total Expenditure -11 -8 -8 -8 -8 -6 -10 -9 -7 -7
PBIDT -3 0 0 1 1 1 3 4 3 3
Interest 0 -1 -1 -1 -1 -1 0 -1 -1 -1
Depreciation -1 -2 -3 -2 -1 -1 -1 -1 0 0
Taxation 1 0 0 0 0 0 0 0 0 0
Exceptional Items 2 2 2
PAT -4 -2 -2 0 1 0 2 2 2 2
Minority Interest 0 0 0 0 0 0 0
Share Associate
Other Related Items 0 0
Consolidated Net Profit -4 -2 -1 0 1 0 2 2 2 2
Adjusted EPS -4 -2 -1 0 1 0 2 2 2 2

Medinova Diagnostic Services Ltd. Cash Flow

View details >>
Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -1 0 1 1 1 2 1 1
Cash Fr. Inv. -5 0 0 0 0 0 -2 0
Cash Fr. Finan. 5 0 -2 -1 -1 -1 0 -1
Net Change 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 1

Medinova Diagnostic Services Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 62.14 62.14 62.14 62.14 62.14 62.14 62.14 62.14 62.14
Public 37.86 37.86 37.86 37.86 37.86 37.86 37.86 37.86 37.86
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Medinova Diagnostic Services Ltd. Announcements

View details >>
Fri, 19 Apr 2024
Board Meeting Intimation for Approval Of The Audited Financial Results For The Quarter And Year Ended 31St March 2024
MEDINOVA DIAGNOSTIC SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2024 inter alia to consider and approve Audited Financial Results for the quarter and year ended 31st March 2024 and other business matters
Mon, 08 Apr 2024
Compliance Certificate For The Financial Year Ended March 31 2024
Compliance Certificate U/R 7(3) of SEBI(LODR)Regulations 2015
Thu, 04 Apr 2024
Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations 2015 For The Year Ended 31St March 2024
Certificate U/R 40(9) of SEBI(LODR)Regulations 2015 for the year ended March 31 2024

Medinova Diagnostic Services Ltd. Technical Scans

View details >>
Mon, 22 Apr 2024
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Medinova Diagnostic Services Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 369,401.61 1,484.65 -3.6%
Cipla Ltd. 109,341.46 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. 100,341.19 5,952.10 -1.1%
Divi's Laboratories Ltd. 99,176.41 3,768.65 +0.8%
Zydus Lifesciences Ltd. 96,543.12 959.45 0.0%
Mankind Pharma Ltd. 93,651.57 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. 89,650.45 6,194.90 -0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.48 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 29.49 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.19 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-12 71.71 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.46 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 54.22 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 113.58 6,194.90 -0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.92 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 4.22 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.73 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-12 7.61 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.12 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 10.54 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.27 6,194.90 -0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,194.90 -0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,194.90 -0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,194.90 -0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,194.90 -0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,194.90 -0.7%

Medinova Diagnostic Services Ltd. FAQ's

What is Medinova Diagnostic share price?
Can I buy Medinova Diagnostic shares now?
What is the Market Cap of Medinova Diagnostic?
What are the key metrics to analyse Medinova Diagnostic?
What is the 52 Week High and Low of Medinova Diagnostic?
What is the trend of Medinova Diagnostic share price?